Crossmark Global Holdings’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267K | Sell |
|
|||||
|
2025
Q1 | $372K | Sell |
|
|||||
|
2024
Q4 | $459K | Sell |
|
|||||
|
2024
Q3 | $524K | Sell |
|
|||||
|
2024
Q2 | $827K | Buy |
|
|||||
|
2024
Q1 | $651K | Buy |
|
|||||
|
2023
Q4 | $310K | Sell |
|
|||||
|
2023
Q3 | $372K | Sell |
|
|||||
|
2023
Q2 | $377K | Sell |
|
|||||
|
2023
Q1 | $358K | Buy |
|
|||||
|
2022
Q4 | $330K | Buy |
|
|||||
|
2022
Q3 | $304K | Sell |
|
|||||
|
2022
Q2 | $287K | Sell |
|
|||||
|
2022
Q1 | $279K | Buy |
|
|||||
|
2021
Q4 | $234K | Buy |
|
|||||
|
2021
Q3 | $275K | Sell |
|
|||||
|
2021
Q2 | $261K | Sell |
|
|||||
|
2021
Q1 | $485K | Sell |
|
|||||
|
2020
Q4 | $521K | Sell |
|
|||||
|
2020
Q3 | $394K | Sell |
|
|||||
|
2020
Q2 | $416K | Buy |
|
|||||
|
2020
Q1 | $417K | Sell |
|
|||||
|
2019
Q4 | $488K | Sell |
|
|||||
|
2019
Q3 | $634K | Sell |
|
|||||
|
2019
Q2 | $635K | Sell |
|
|||||
|
2019
Q1 | $493K | Buy |
|
|||||
|
2018
Q4 | $555K | Buy |
|
|||||
|
2018
Q3 | $529K | Sell |
|
|||||
|
2018
Q2 | $420K | Sell |
|
|||||
|
2018
Q1 | $595K | Sell |
|
|||||
|
2017
Q4 | $585K | Buy |
|
|||||
|
2017
Q3 | $442K | Buy |
|
|||||
|
2016
Q3 | $442K | Buy |
|